Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$554M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$435M |
| 3 |
CERN
Cerner Corp
CERN
|
+$282M |
| 4 |
Norfolk Southern
NSC
|
+$238M |
| 5 |
ExxonMobil
XOM
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.35B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$966M |
| 4 |
NVIDIA
NVDA
|
+$768M |
| 5 |
AT&T
T
|
+$594M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 59.52% |
| 2 | Technology | 7.24% |
| 3 | Financials | 6.69% |
| 4 | Healthcare | 6.46% |
| 5 | Industrials | 4.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CIIG
3076
DELISTED
CIIG Capital Partners II, Inc. Class A Common Stock
CIIG
| $4.16M | ﹤0.01% |
419,730
+219,730
| +110% | +$2.17M |
|
3077
Rhythm Pharmaceuticals
RYTM
$7.38B
| $4.15M | ﹤0.01% |
360,592
+46,888
| +15% | +$412K |
|
|
BREZ
3078
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
| $4.15M | ﹤0.01% |
402,500
+367,639
| +1,055% | +$3.77M |
|
|
LITT
3079
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
| $4.15M | ﹤0.01% |
426,940
+1,940
| +0.5% | +$18.8K |
|
|
GAQ
3080
DELISTED
Generation Asia I Acquisition Limited Class A Ordinary Shares
GAQ
| $4.15M | ﹤0.01% |
+423,512
| New | +$4.13M |
|
3081
Shore Bancshares
SHBI
$772M
| $4.14M | ﹤0.01% |
202,325
+162,969
| +414% | +$3.34M |
|
3082
CALL
First Horizon
FHN
$11.7B
| $4.14M | ﹤0.01% |
+176,300
| New | +$3.52M |
|
3083
Atara Biotherapeutics
ATRA
$92.3M
| $4.13M | ﹤0.01% |
17,803
+16,136
| +968% | +$5.14M |
|
|
3084
PUT
First Horizon
FHN
$11.7B
| $4.13M | ﹤0.01% |
+176,000
| New | +$3.51M |
|
|
TCDA
3085
DELISTED
Tricida, Inc. Common Stock
TCDA
| $4.13M | ﹤0.01% |
502,713
+376,783
| +299% | +$3.41M |
|
3086
PUT
Phillips 66
PSX
$97.4B
| $4.13M | ﹤0.01% |
47,800
| – | – |
|
3087
iShares Fallen Angels USD Bond ETF
FALN
$1.66B
| $4.12M | ﹤0.01% |
+148,577
| New | +$4.21M |
|
3088
Illinois Tool Works
ITW
$79.8B
| $4.12M | ﹤0.01% |
19,689
+4,954
| +34% | +$1.11M |
|
3089
TaskUs
TASK
$769M
| $4.12M | ﹤0.01% |
+107,024
| New | +$3.77M |
|
3090
Associated Banc-Corp
ASB
$5.84B
| $4.11M | ﹤0.01% |
180,491
+132,091
| +273% | +$3.2M |
|
3091
GCM Grosvenor
GCMG
$839M
| $4.11M | ﹤0.01% |
422,955
+145,956
| +53% | +$1.44M |
|
3092
Citi Trends
CTRN
$560M
| $4.11M | ﹤0.01% |
134,085
-159,285
| -54% | -$7.44M |
|
|
TPGY
3093
DELISTED
TPG Pace Beneficial Finance Corp.
TPGY
| $4.11M | ﹤0.01% |
413,516
| – | – |
|
|
CLRM
3094
DELISTED
Clarim Acquisition Corp. Class A Common Stock
CLRM
| $4.11M | ﹤0.01% |
418,920
-443,320
| -51% | -$4.32M |
|
3095
Nomad Foods
NOMD
$1.66B
| $4.1M | ﹤0.01% |
181,627
+171,158
| +1,635% | +$4.16M |
|
3096
Immersion
IMMR
$254M
| $4.1M | ﹤0.01% |
737,070
-527,294
| -42% | -$2.73M |
|
3097
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$299M
| $4.1M | ﹤0.01% |
200,000
-8,000
| -4% | -$154K |
|
3098
Freshworks
FRSH
$3.62B
| $4.09M | ﹤0.01% |
228,349
+204,069
| +840% | +$4.15M |
|
3099
BCB Bancorp
BCBP
$156M
| $4.09M | ﹤0.01% |
224,180
+49,726
| +29% | +$869K |
|
|
GAP
3100
The Gap Inc
GAP
$8.45B
| $4.08M | ﹤0.01% |
289,710
-280,241
| -49% | -$4.47M |
|
Similar funds
Israel Englander's Q1 2022 Portfolio in Review
As of Q1 2022, Israel Englander held 8,193 positions worth $189B, down 4.1% from $197B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Israel Englander's Q1 2022 filing shows 1,491 new, 2,450 increased, 2,453 reduced and 1,365 closed positions. Its largest new stake was Mondelez International: 1,780,636 shares worth $112M. The largest sale was iShares Core S&P 500 ETF, an estimated $1.35B.
By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, up from 58% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q1 2022 buy was Mondelez International: 1,780,636 shares worth $112M.
- Israel Englander added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $554M increase.
- Israel Englander's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.35B.
- Israel Englander fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $532M.
- Israel Englander's ten largest holdings make up 24% of its $189B portfolio in Q1 2022.
- Israel Englander opened 1,491 new positions and closed 1,365 in Q1 2022.
- Israel Englander's portfolio value fell 4.1% quarter-over-quarter to $189B.
Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.